top of page

Our research aims to improve the treatment of patients suffering from cancer and autoimmune disease . We study the response of tumors to the immune system, as well as mechanisms to promote immune cells’ capacity to recognize and eliminate malignant tumor cells.

​

Michael Peled, MD, PhD, is an Assistant Professor of Medicine in the Institute of Pulmonary Medicine at Sheba Medical Center, affiliated to Tel Aviv University. He heads the Peled Lab, located in the Sheba Cancer Research Center.

Our Research

GREEN_3193_04222021_0757.jpg
alk_peptide.tif

​Our research program combines state-of-the art approaches including in vivo and in vitro studies, proteomics, genomics, molecular biology and imaging.

Latest Publications

Mooshayef N, Barhom H, Chatterji S, Hecht N, Warhaftig O, Kamer I, Zadok O, Bar J, Broday L, Onn A, Peled M. Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing.                                       Molecular Oncology, 2025

BT3A7000.jpg

Research Support

isf_logo_edited_edited_edited.jpg
1248px-The_Israel_Cancer_Association_Log.webp
רשות החדשנות.jpg
Contact

Contact Us

Open positions are available for MSc and PhD  students.

For more information, please contact:

Sheba Medical Center, Ramat Gan, Israel

  • Twitter

© 2023 by Tel Aviv University. Proudly created with Wix.com

bottom of page